Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Cancer

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biomarkers of psychiatric diseases: current status and future prospects.

Metabolism: clinical and experimental·2014

Same author

Biomarkers for personalized oncology: recent advances and future challenges.

Metabolism: clinical and experimental·2014

Same author

New therapeutics for pain--an overview.

Metabolism: clinical and experimental·2010

Same author

The role of corticosteroids and stress in chronic pain conditions.

Metabolism: clinical and experimental·2010

Same author

Brain development: anatomy, connectivity, adaptive plasticity, and toxicity.

Metabolism: clinical and experimental·2008

Same author

Neurobiology of sleep.

Metabolism: clinical and experimental·2006

Search research articles

Related Experiment Video

Updated: May 18, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

Personalized oncology: recent advances and future challenges.

¹Department of Biochemistry, Jefferson Medical College of Thomas Jefferson University, Suite 520, 1020 Walnut Street, Philadelphia, PA 19107, USA. mkalia@msn.com

Metabolism: Clinical and Experimental

|September 25, 2012

Summary

Personalized oncology uses biomarkers for tailored cancer care, improving outcomes and reducing costs. This evidence-based approach shifts cancer treatment from reactive to proactive, utilizing genomic analysis and molecular diagnostics for individual patient needs.

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Related Experiment Videos

Last Updated: May 18, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Area of Science:

Oncology
Genomics
Molecular Diagnostics

Background:

Personalized oncology represents a shift from traditional 'one size fits all' medicine to individualized patient care.
It leverages evidence-based, targeted treatments for optimal cancer management.
The field is evolving with advancements in genomic analysis, targeted therapies, and molecular diagnostics.

Purpose of the Study:

To review evolving topics in personalized oncology, including genomic analysis, targeted drugs, cancer therapeutics, and molecular diagnostics.
To highlight the critical role of validated biomarkers in tailoring cancer treatment.
To discuss the future of cancer care as a proactive discipline driven by molecular insights.

Main Methods:

Review of current literature on personalized oncology, biomarkers, and molecular diagnostics.
Discussion of the impact of genomic analysis and targeted therapies.
Exploration of advancements in imaging technologies and their integration into cancer management.

Main Results:

Biomarkers (predictive, prognostic, early response) are essential for personalized oncology, enabling tailored treatments.
Molecular diagnostics identify patients likely to respond to specific targeted therapies.
Imaging technologies like CT and PET, especially molecular imaging, are crucial for early detection and management.

Conclusions:

Personalized oncology, driven by biomarkers and molecular diagnostics, significantly improves patient outcomes and reduces healthcare costs.
The integration of molecular diagnostics with targeted therapies offers greater efficiency and value.
Future cancer treatment will be proactive, precise, and highly individualized, enhancing prevention and management.